What the buyer wrote
H&I is a strategic business function of NHSBT, providing testing and support in transplantation and specialised transfusion including the supply of selected blood products, immunogenetics, platelet and granulocyte immunology. The requirement for this procurement is for the supply and support of HLA Next Generation Sequencing for clinical samples. This will be for equipment, maintenance and all reagents and consumables. This Framework Agreement is divided into lots: Lot 1 - Equipment; Lot 2 - Kits, Lot 3 - Canadian requirements. This Framework Agreement is for a period of 4 years. It is the intention of NHSBT to award a Framework Agreement for these requirements by 15 June 2017. The following…
Details
- What the buyer calls it
- HLA Next Generation Sequencing Systems
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 31 May 2018
- Work ends
- 31 May 2021
- Kind of work
- Medical equipment and consumables
Who the buyer named
The buyer published a contact address on this notice.